NRCC
NOTICE OF REGISTRATION CONFIRMATION EMAILED
10/02/2026
Voltar para busca
Dado oficial do USPTO
JEMIQTA
Sabia que essa marca já está registrada no Estados Unidos?
Antes de investir em nome, identidade e divulgação, valide risco de colisão e estratégia de registro para não perder tempo nem budget.
Active USPTO registrationTipo: VerbalEscritório: US
Diagnóstico de risco e oportunidade
Leitura executiva para decisão de naming, protocolo e monitoramento.
Situação USPTO
Active USPTO registration
Tipo de processo
Pedido e registro
Eventos registrados
16
Atualização mais recente
11/02/2026
Classificação
Registrada
Tipo de marca
Verbal
Classes Nice
5, 10
Data de depósito
14/07/2025
Data de registro
10/02/2026
Data de expiração
-
Ação recomendada
Execute uma análise de colidência completa e valide classes antes de qualquer protocolo ou investimento de marca.
Próximo passo
Esses são os detalhes do processo de registro. Mesmo assim, o monitoramento constante é o que garante tranquilidade de que o seu principal ativo continue protegido.
Dados completos do processo
Campos estruturados da autoridade responsável e do histórico oficial.
Data da situação
10/02/2026
Última transação
11/02/2026
Escritório responsável
United States Patent and Trademark Office
Código da situação
700
Cadastro oficial
Principal Register
Fundamento do pedido
Foreign priority
Código do desenho
4
Tipo de titular
65
Localização do titular
Valby, DK
Examinador
MATZINGER, AMY L
Unidade examinadora
N90
Localização atual
FILE REPOSITORY (FRANCONIA)
Titulares e representantes
Titulares
H. Lundbeck A/S
Representantes
Maren Perry KING & SPALDING LLP
Classificação técnica
Classes Nice
Classe 5Classe 10
Códigos Vienna
Sem códigos Vienna disponíveis.
Produtos e serviços
Classe 5
Sanitary preparations for medical purposes; dietetic preparations for medical use; vaccines; pharmaceutical preparations and substances for the prevention and treatment of disorders and diseases ofgenerated from and affecting the central nervous system; pharmaceutical preparations and substances for the treatment of central nervous system disorders; central nervous system stimulants; pharmaceutical preparations and substances for the diagnosisprevention and treatment of psychiatricneurologicalneurohormonalneurogeneticneuroendocrinological and autoimmune diseases and disorders; pharmaceutical preparations and substances for diagnosisprevention and treatment of dementiaAlzheimer's diseasedepressionpsychosisanxietyLennox-Gastaut diseaseepilepsyDravet SyndromeDevelopmental and Epileptic Encephalopathy (DEE)alpha-synucleinopathiesMultiple System Atrophy (MSA)dementia with Lewy bodiesrapid eye movement (REM) sleep behavior syndromeporphyriaHuntington's diseaseinsomniaParkinson's diseasesclerosismultiple sclerosisschizophreniabipolar disordercancerpainmigraineheadacheHorton's headachetraumatic brain injurypost-traumatic brain injurydizzinessseizuresstrokecognitive impairmentcognitive disorders and diseasesmood disordersfallsmovement disorders and diseasestremoragitationmaniaaggressionautismmelancholiaObsessive Compulsive Disorder (OCD)Tourette's syndromerestlessnessakathisiafatiguesomnolencenauseaCushing's diseaseAdrenogenital syndrome (AGS)narcolepsyPost-Traumatic Stress Disorder (PTSD)Attention Deficit Hyperactivity Disorder (ADHD)Progressive Supranuclear Palsy (PSP)Thyroid Associated Orbitopathy (TAO)Graves OrbitopathyHashimoto's Thyroiditisalcoholism and addiction; diagnostic agents and preparations for medical purposes; chemical substances for diagnostic and medical purposeschemical reagents for medical usediagnostic chemical reagents for medical purposes; medical diagnostic reagents
Classe 10
Medical apparatusinfusion and injection devices for administering drugs; Medical syringesintravenous bags sold empty for intravenous therapyintravenous (IV) feeding tubesintravenous (IV) infusion pumpsintravenous (IV) catheters; injection devices for administering drugssyringes and needles for injections and medical purposes; Apparatus and instruments for diagnostic purposesdosage management dispensers for administering medicinesincorporating downloadable and recorded software for medical information management for use in web-based physical and psychological examination and assessment of patients at a distance and at a clinic; Medical devices and instruments for use in the diagnosismedicine administrationmonitoringassessmentcontrol and examination of psychiatricneurologicalneurohormonalneurogeneticneuroendocrinological and autoimmune disorders and diseases; integrated medical systems comprising of medical instruments for diagnostics and examination of patients and downloadable software for processing patient intake and communications and information managementall for use in the examination and assessment of patients and clients; integrated medical systems comprised of medical instruments for treating central nervous system diseases and disorders and psychiatricneurologicalneurohormonalneurogeneticneuroendocrinological and autoimmune disorders and diseasesall for the purposes of managementmeasurementmonitoringevaluationcontrolcollectionstoragetransmission and examination of patient and client data and information; medical instrumentsdevices for delivery and administering of medicines in the nature of infusion and injection devices and infusion pumps for providing medication administering informationguidancemanagement
Publicações
Histórico de despachos e eventos da marca no USPTO.
16 publicações encontradas
R.PR
REGISTERED-PRINCIPAL REGISTER
10/02/2026
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
23/12/2025
PUBO
PUBLISHED FOR OPPOSITION
23/12/2025
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
17/12/2025
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
25/11/2025
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
24/11/2025
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
24/11/2025
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
24/11/2025
GNRN
NOTIFICATION OF NON-FINAL ACTION E-MAILED
23/09/2025
GNRT
NON-FINAL ACTION E-MAILED
23/09/2025
CNRT
NON-FINAL ACTION WRITTEN
23/09/2025
DOCK
ASSIGNED TO EXAMINER
19/09/2025
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
14/07/2025
MAFR
APPLICATION FILING RECEIPT MAILED
14/07/2025
NWAP
NEW APPLICATION ENTERED
14/07/2025
Proteção contínua da sua marca
Seja avisado a cada novo depósito que ameace JEMIQTA ou a sua marca.
Vigilância profissional por 24 meses: monitoramos o USPTO por você e alertamos a tempo de você se opor — antes que o conflito vire prejuízo.